
Home | NeoGenomics Laboratories
With over a decade of experience, NeoGenomics has contributed to a wealth of research, uncovering insights to advance breakthroughs in cancer diagnostics. Our expertise in real-world evidence (RWE) …
Login - NeoGenomics
We’re proud of the impact our teams have made and of our President and COO, Warren Stone, for sharing how NeoGenomics helps ensure patients receive high-quality care close to home through …
Search our test menu | NeoGenomics Laboratories
Contact us online Get in touch Our Client Services team is on hand to help. Please call us at 866.776.5907, Option 3. Copyright © 2025 NeoGenomics Laboratories. All rights reserved. About …
About NeoGenomics Laboratories | Healthcare Testing Solutions
Dec 15, 2025 · NeoGenomics is committed to innovation in cancer diagnostics, providing comprehensive testing solutions to advance precision medicine for your patients.
NeoGenomics
Copyright © 2026 NeoGenomics Laboratories. All rights Reserved. Privacy. Terms. Licensing. Do not sell or share my personal information.
Client support & resources | NeoGenomics Laboratories
NeoGenomics is licensed under the Clinical Laboratory Improvement Amendments (CLIA) of 1988 and is authorized to provide diagnostic laboratory services in the states of California, Florida, Maryland, …
Contact us | NeoGenomics Laboratories
Patient Support T: 866.776.5907, Option 9 E: [email protected] Hours of Operation: Monday – Friday: 8 am to 5 pm ET After Hours: After normal business hours, 7 days per week
Patients | NeoGenomics Laboratories
At NeoGenomics, our priority is patient health. Every day, we are improving access to diagnostic tools that can advance patient outcomes through transformative oncology testing.
NeoGenomics, Inc. (NEO)
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them …
NeoGenomics Completes Acquisition of Pathline
Apr 7, 2025 · With the acquisition, NeoGenomics strengthens its commercial presence in the Northeast U.S. and broadens access to its comprehensive oncology test menu, expands its service capabilities, …